Biobot Analytics
YC W18 ↗Boston, US · Founded 2017 · Delaware corporation · 12 employees · 12 known investors
Biobot pioneers wastewater epidemiology, monitoring pathogens and substances in sewage to provide real-time public health surveillance at the community level. The company serves public health agencies, vaccine manufacturers, and hospital systems globally.
BiotechData & InfrastructureGovTechHealthtechHealth TechAnalyticsin /company@biobotanalyticsycombinator.com ↗
Founders & leadership· Y Combinator alumni (W18)
Investors · 12
American Family Insurance Institute for Corporate and Social ImpactMadison
Blindspot Ventures Management CoBoston
DCVC (Data Collective)Palo Alto · $5M – $25M
Dorm RoomBrooklyn · $90K – $250K
HomebrewBurlingame · $100K – $500K
Pathbreaker VenturesSan Francisco · $250K – $1Mvia Ryan Gembala · inferred
Plum Alley InvestmentsNew York · $500K – $1.5M
The Engine VenturesCambridge
Y CombinatorSan Francisco · $500K
GreatPoint VenturesreportedSan Francisco · $250K – $20M
Hyperplane Venture CapitalreportedBoston · $250K – $3M
Thursday VenturesreportedBrandon
Reported raises · per SEC filings
Form D private placements▶$13.5MraisedJun 2025 · 46 investors · Other TechnologyRule 506(b)
▶$13.5MraisedJun 2025 · 46 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Vivek PattipatiDirector
- Newsha GhaeliExecutive Officer, Director
- Andrew PerlmanDirector
- Mariana Guadalupe Matus GarciaExecutive Officer, Director
- Offering amount
- $13.6M
- Amount sold
- $13.5M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.8MraisedNov 2021 · 26 investors · OtherRule 506(b)
▶$20.8MraisedNov 2021 · 26 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mariana Guadalupe Matus GarciaExecutive Officer, Director
- Rich-Henry SchabowskyDirector
- Newsha GhaeliExecutive Officer, Director
- Ann DeWittDirector
- Offering amount
- $20.8M
- Amount sold
- $20.8M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$6.7MraisedApr 2020 · 29 investors · BiotechnologyRule 506(b)
▶$6.7MraisedApr 2020 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Newsha GhaeliExecutive Officer, Director
- Mariana Guadalupe Matus GarciaExecutive Officer, Director
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Biobot readies for expansion into new markets - Cambridge Daycambridgeday.com · 2025
- Biobot Analytics Awarded NIDA Funding for Nationwide Wastewater-Based Monitoring Program for High Risk Substances and Others Associated with Health Risksprnewswire.com · 2023
- The Cambridge startup tracking COVID in Americaâs waste water - The Boston Globebostonglobe.com · 2022
- Raising $20M Series A to Expand Wastewater Epidemiologybiobot.io · 2021
- MIT Spinoff Raises $4.2 Million To Estimate Scope Of Coronavirus Cases By Analyzing Poopforbes.com · 2020
- Biobot Analytics Raises $6.7 Million In Round Led By MIT's The Enginepulse2.com · 2020
- Biobot Analytics Raises $6.7M in Seed Funding - FinSMEsfinsmes.com · 2020
- Biobot Analytics Raises $6.7 Million in Seed Funding to Transform Wastewater Infrastructure into Public Health Observatoriesstreetinsider.com
